CEimpact Podcast

STIs Part I: Candidiasis, Trichomoniasis, and Bacterial Vaginosis

May 23, 2022 CEimpact Season 3 Episode 21
CEimpact Podcast
STIs Part I: Candidiasis, Trichomoniasis, and Bacterial Vaginosis
Show Notes

The Centers for Disease Control and Prevention just updated guidelines for sexually transmitted infections (previously sexually transmitted diseases) for everything but HIV. In this multi-part series, host Geoff Wall will break down what’s new and what’s changing in practice.

The GameChanger 
Maintenace treatment for recurrent vulvovaginal candidiasis is marginally effective. The standard of care in the treatment of trichomoniasis is now metronidazole for seven days. Current data do not suggest routine treatment of male partners of women with bacterial vaginosis.  

Show Segments 
00:00 – Introductions 
01:20 – STI Guidelines 
02:20 – Vaginal Candidiasis  
11:12 – Trichomoniasis  
19:23 – Bacterial Vaginosis  
26:06 – Closing Remarks  

Host 
Geoff Wall, PharmD., BCPS, FCCP, CGP 
Professor of Pharmacy Practice, Drake University 
Internal Medicine/Critical Care, UnityPoint Health 

All relevant financial relationships have been mitigated. 

References and Resources 

Redeem your CPE or CME.

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)

CE Information 

Learning Objectives 

  1. Describe the new recommendations for treatment of candidiasis
  2. Discuss changes in duration of therapy for treatment of trichomoniasis
  3. Identify treatment options for bacterial vaginosis

0.05 CEU/0.5 Hr
UAN: 0107-0000-22-222-H01-P
Initial release date: 05/23/2022
Expiration date: 05/23/2023
Additional CPE and CME details can be found here